Truist Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Sell |
2,171
-277
| -11% | -$31.5K | ﹤0.01% | 2287 |
|
|
2025
Q1 | $257K | Sell |
2,448
-48
| -2% | -$5.05K | ﹤0.01% | 2212 |
|
|
2024
Q4 | $267K | Sell |
2,496
-149
| -6% | -$16K | ﹤0.01% | 2196 |
|
|
2024
Q3 | $265K | Buy |
+2,645
| New | +$265K | ﹤0.01% | 2194 |
|
|
2021
Q1 | – | Sell |
-2,608
| Closed | -$162K | – | 2663 |
|
|
2020
Q4 | $162K | Sell |
2,608
-4,283
| -62% | -$266K | ﹤0.01% | 2394 |
|
|
2020
Q3 | $410K | Sell |
6,891
-2,490
| -27% | -$148K | ﹤0.01% | 1804 |
|
|
2020
Q2 | $654K | Buy |
9,381
+3,224
| +52% | +$225K | ﹤0.01% | 1476 |
|
|
2020
Q1 | $279K | Buy |
6,157
+189
| +3% | +$8.56K | ﹤0.01% | 1882 |
|
|
2019
Q4 | $389K | Buy |
5,968
+2,150
| +56% | +$140K | ﹤0.01% | 1991 |
|
|
2019
Q3 | $237K | Sell |
3,818
-138
| -3% | -$8.57K | ﹤0.01% | 719 |
|
|
2019
Q2 | $282K | Sell |
3,956
-271
| -6% | -$19.3K | ﹤0.01% | 695 |
|
|
2019
Q1 | $332K | Buy |
4,227
+806
| +24% | +$63.3K | 0.01% | 653 |
|
|
2018
Q4 | $289K | Sell |
3,421
-274
| -7% | -$23.1K | 0.01% | 653 |
|
|
2018
Q3 | $632K | Sell |
3,695
-133
| -3% | -$22.7K | 0.01% | 548 |
|
|
2018
Q2 | $494K | Sell |
3,828
-338
| -8% | -$43.6K | 0.01% | 578 |
|
|
2018
Q1 | $429K | Sell |
4,166
-37
| -0.9% | -$3.81K | 0.01% | 598 |
|
|
2017
Q4 | $359K | Sell |
4,203
-93
| -2% | -$7.94K | 0.01% | 647 |
|
|
2017
Q3 | $365K | Sell |
4,296
-26
| -0.6% | -$2.21K | 0.01% | 640 |
|
|
2017
Q2 | $327K | Sell |
4,322
-133
| -3% | -$10.1K | 0.01% | 654 |
|
|
2017
Q1 | $294K | Sell |
4,455
-447
| -9% | -$29.5K | 0.01% | 698 |
|
|
2016
Q4 | $311K | Sell |
4,902
-394
| -7% | -$25K | 0.01% | 689 |
|
|
2016
Q3 | $337K | Buy |
5,296
+1,248
| +31% | +$79.4K | 0.01% | 665 |
|
|
2016
Q2 | $301K | Buy |
+4,048
| New | +$301K | 0.01% | 686 |
|